Treatment and follow-up of children with chronic myeloid leukemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era – Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort
Roy Moulik N et al. Br J Haematol, December 2023 (epub ahead of print)
Link to full abstract